Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Developer of p300/CBP small-molecule inhibitor drug to treat cancer. | ||||||
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. | ||||||
Intercytex Group is a company founded in 2000. | ||||||
Takeda Cambridge is a company in the pharmaceuticals industry. | ||||||